This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.
Latest papers
In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer.
Nature communications · 2026
Molecular insights into the PRLR-Hippo-YAP axis in breast cancer therapeutics.
Expert opinion on therapeutic targets · 2026 · first author
Identification of HSPE1 as a new actionable cancer vulnerability leads to an innovative and effective combination therapy for pancreatic ductal adenocarcinoma.
Molecular cancer · 2026
Latest funding
- $1,396,126
Unraveling Prolactin's Role in Women's Health: From Mammary Differentiation to Tumor Suppression
CIHR · 2026 · Nominated PI
- $1,036,575
Pharmacological Targeting of Adenosine-to-Inosine (A-to-I) RNA Editing in Aggressive Breast Cancer Subtypes
CIHR · 2022 · Nominated PI
- $1,220,175
Exploiting a novel dual-specificity cell cycle inhibitor, KP108 as a therapeutic approach for metastatic breast cancer
CIHR · 2022 · Co-investigator
41 publications.
In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer.
Galal S, Chaltel Lima L, Wang N, Moury C, Yan G, Dai M, Ali S, Lebrun JJ
Molecular insights into the PRLR-Hippo-YAP axis in breast cancer therapeutics.
Ali S, Lebrun JJ
Identification of HSPE1 as a new actionable cancer vulnerability leads to an innovative and effective combination therapy for pancreatic ductal adenocarcinoma.
Boudreault J, Rahimirad S, Wang N, Yan G, Lima LC, Poulet S, Dai M, Ali S, Lebrun JJ
A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer.
Liu X, Moamer A, Gomes da Silva R, Shoham-Amizlev A, Hamam D, Shams A, Lebrun JJ, Ali S
Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.
Laham AJ, El-Awady R, Saber-Ayad M, Wang N, Yan G, Boudreault J, Ali S, Lebrun JJ
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.
Laham AJ, El-Awady R, Saber-Ayad M, Wang N, Yan G, Boudreault J, Ali S, Lebrun JJ
Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in Melanoma.
Boudreault J, Canaff L, Ghozlan M, Wang N, Guarnieri V, Salcuni AS, Scillitani A, Goltzman D, Ali S, Lebrun JJ
Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer.
Poulet S, Dai M, Wang N, Yan G, Boudreault J, Daliah G, Guillevin A, Nguyen H, Galal S, Ali S, Lebrun JJ
Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance.
Yan G, Dai M, Poulet S, Wang N, Boudreault J, Daliah G, Ali S, Lebrun JJ
Study protocol for the sheMATTERS study (iMproving cArdiovascular healTh in new moThERS): a randomized behavioral trial assessing the effect of a self-efficacy enhancing breastfeeding intervention on postpartum blood pressure and breastfeeding continuation in women with hypertensive disorders of pregnancy.
Dayan N, Smith G, Nedelchev A, Abenhaim H, Brown R, Da Costa D, Ali S, Perlman J, Nguyen TV, Dennis CL, Abdelmageed W, Semenic S
Unraveling Prolactin's Role in Women's Health: From Mammary Differentiation to Tumor Suppression
Principal investigators: Ali, Suhad
Keywords: Maternal Health
Pharmacological Targeting of Adenosine-to-Inosine (A-to-I) RNA Editing in Aggressive Breast Cancer Subtypes
Principal investigators: Ali, Suhad
Keywords: Pharmacological Studies
Exploiting a novel dual-specificity cell cycle inhibitor, KP108 as a therapeutic approach for metastatic breast cancer
Principal investigators: Lebrun, Jean-Jacques
Keywords: Cancer Stem Cell Therapy; Cdk4/6 Inhibitors; Computational Modeling; Drug Development; Dual Targeting Kinase Inhibitors; Metastatic Cancer; Plk1 Inhibitors; Preclinical Models Of Breast Cancer; Structure-Based Drug Discovery And Design; Triple Negative Breast Cancer
Molecular and Mechanistic Investigations of the Role of Prolactin in Women's Health: A Focus on Breast Morphogenesis and Suppression of Tumorigenesis
Principal investigators: Ali, Suhad
Keywords: Women'S Health
A Molecular and Mechanistic Investigation into the Benefits of Breastfeeding in Women's Health
Principal investigators: Ali, Suhad
Keywords: Breast Cancer; Breastfeeding; Women'S Health
Role of SHP-2 in Prolactin Hormone Signaling in Mammary Epithelial Cell Differentiation and Morphogenesis
Principal investigators: Ali, Suhad
Keywords: Breast Cancer; Hormone Action; Signal Transduction
Regulation of Prolactin Signaling by Protein Tyrosine Phosphatases
Principal investigators: Ali, Suhad
Keywords: Animal Model; Breast Cancer; Cell Culture; Hormone Action; Prolactin; Protein Tyrosine Phosphatase
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Morag Park and Morag Park: 116 shared papers
- Jean-Jacques Lebrun and Suhad Ali: 36 shared papers
- Deborah Da Costa and Cindy-Lee Dennis: 8 shared papers
- Deborah Da Costa and Tuong-Vi Nguyen: 6 shared papers
- Tuong-Vi Nguyen and Natalie Dayan: 4 shared papers
- Deborah Da Costa and Natalie Dayan: 3 shared papers
- Graeme Smith and Natalie Dayan: 2 shared papers
- Natalie Dayan and Richard Brown: 2 shared papers
- Haim Abenhaim and Deborah Da Costa: 1 shared paper
- Haim Abenhaim and Cindy-Lee Dennis: 1 shared paper
- Haim Abenhaim and Graeme Smith: 1 shared paper
- Haim Abenhaim and Tuong-Vi Nguyen: 1 shared paper
- Haim Abenhaim and Richard Brown: 1 shared paper
- Haim Abenhaim and Suhad Ali: 1 shared paper
- Deborah Da Costa and Graeme Smith: 1 shared paper
- Deborah Da Costa and Richard Brown: 1 shared paper
- Deborah Da Costa and Suhad Ali: 1 shared paper
- Cindy-Lee Dennis and Graeme Smith: 1 shared paper
- Cindy-Lee Dennis and Suhad Ali: 1 shared paper
- Graeme Smith and Suhad Ali: 1 shared paper
- Bertrand Jean-Claude and Jean-Jacques Lebrun: 1 shared paper
- Bertrand Jean-Claude and Suhad Ali: 1 shared paper
- Morag Park and Jean-Jacques Lebrun: 1 shared paper
- Morag Park and Suhad Ali: 1 shared paper
- Tuong-Vi Nguyen and Suhad Ali: 1 shared paper
- Jean-Jacques Lebrun and David Goltzman: 1 shared paper
- Jean-Jacques Lebrun and Morag Park: 1 shared paper
- David Goltzman and Suhad Ali: 1 shared paper
- Natalie Dayan and Suhad Ali: 1 shared paper
- Richard Brown and Suhad Ali: 1 shared paper
- Suhad Ali and Morag Park: 1 shared paper
- Medicine
- School of Nursing
- Oncology
- Nutritional Sciences
- Clinical Epidemiology & Community Studies
- Medicine/Obstetrics & Gynecology
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Jean-Jacques Lebrun
Medicine
36 shared papers, latest 2026
Morag Park
Oncology
1 shared papers, latest 2014
Deborah Da Costa
School of Nursing
1 shared papers, latest 2023
Cindy-Lee Dennis
Nutritional Sciences
1 shared papers, latest 2023
Graeme Smith
School of Nursing
1 shared papers, latest 2023
Bertrand Jean-Claude
Medicine
1 shared papers, latest 2018
Morag Park
Oncology
1 shared papers, latest 2014
Tuong-Vi Nguyen
Faculty
1 shared papers, latest 2023
David Goltzman
Medicine
1 shared papers, latest 2024
Natalie Dayan
Faculty
1 shared papers, latest 2023
Haim Abenhaim
Clinical Epidemiology & Community Studies
1 shared papers, latest 2023
Richard Brown
Medicine/Obstetrics & Gynecology
1 shared papers, latest 2023
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.